Evaluation of the paclitaxel–ifosfamide–cisplatin (TIP) combination in relapsed and/or metastatic cervical cancer

BACKGROUND: Recurrent or metastatic cervical cancer represents an aggressive malignancy with a high rate of locoregional and distant failure. Therefore, we evaluated the three-drug combination of paclitaxel–ifosfamide–cisplatin (TIP). METHODS: Systemic chemotherapy-naive patients with advanced metas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kosmas, C, Mylonakis, N, Tsakonas, G, Vorgias, G, Karvounis, N, Tsavaris, N, Daladimos, T, Kalinoglou, N, Malamos, N, Akrivos, T, Karabelis, A
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2009
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768083/
https://ncbi.nlm.nih.gov/pubmed/19738606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605305
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados